Literature DB >> 23135546

Upconversion nanoparticles and their composite nanostructures for biomedical imaging and cancer therapy.

Liang Cheng1, Chao Wang, Zhuang Liu.   

Abstract

Upconversion nanoparticles (UCNPs), particularly lanthanide-doped nanocrystals, which emit high energy photons under excitation by the near-infrared (NIR) light, have found potential applications in many different fields, including biomedicine. Compared with traditional down-conversion fluorescence imaging, the NIR light excited upconversion luminescence (UCL) imaging relying on UCNPs exhibits improved tissue penetration depth, higher photochemical stability, and is free of auto-fluorescence background, which promises biomedical imaging with high sensitivity. On the other hand, the unique upconversion process of UCNPs may be utilized to activate photosensitive therapeutic agents for applications in cancer treatment. Moreover, the integration of UCNPs with other functional nanostructures could result in the obtained nanocomposites having highly enriched functionalities, useful in imaging-guided cancer therapies. This review article will focus on the biomedical imaging and cancer therapy applications of UCNPs and their nanocomposites, and discuss recent advances and future prospects in this emerging field.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135546     DOI: 10.1039/c2nr32311g

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  34 in total

Review 1.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

2.  Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles.

Authors:  James Rieffel; Feng Chen; Jeesu Kim; Guanying Chen; Wei Shao; Shuai Shao; Upendra Chitgupi; Reinier Hernandez; Stephen A Graves; Robert J Nickles; Paras N Prasad; Chulhong Kim; Weibo Cai; Jonathan F Lovell
Journal:  Adv Mater       Date:  2015-01-14       Impact factor: 30.849

Review 3.  Design, synthesis, and characterization of graphene-nanoparticle hybrid materials for bioapplications.

Authors:  Perry T Yin; Shreyas Shah; Manish Chhowalla; Ki-Bum Lee
Journal:  Chem Rev       Date:  2015-02-18       Impact factor: 60.622

4.  Investigation of Gd2O3: Er3+/Yb3+ Upconversion Nanoparticles (UCNPs) as a Multi-model Contrast Agent for Functional Optical Coherence Tomography (fOCT).

Authors:  Muktesh Mohan; Raju Poddar
Journal:  J Fluoresc       Date:  2021-01-16       Impact factor: 2.217

Review 5.  Nanoscale materials for hyperthermal theranostics.

Authors:  Bennett E Smith; Paden B Roder; Xuezhe Zhou; Peter J Pauzauskie
Journal:  Nanoscale       Date:  2015-04-28       Impact factor: 7.790

6.  Stem cell tracking with optically active nanoparticles.

Authors:  Yu Gao; Yan Cui; Jerry Ky Chan; Chenjie Xu
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

Review 7.  Upconversion nanoparticles: design, nanochemistry, and applications in theranostics.

Authors:  Guanying Chen; Hailong Qiu; Paras N Prasad; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2014-03-10       Impact factor: 60.622

8.  General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting.

Authors:  Feng Chen; Shreya Goel; Sixiang Shi; Todd E Barnhart; Xiaoli Lan; Weibo Cai
Journal:  Nano Res       Date:  2018-05-08       Impact factor: 8.897

Review 9.  Near-infrared light activated delivery platform for cancer therapy.

Authors:  Min Lin; Yan Gao; Francis Hornicek; Feng Xu; Tian Jian Lu; Mansoor Amiji; Zhenfeng Duan
Journal:  Adv Colloid Interface Sci       Date:  2015-10-14       Impact factor: 12.984

10.  Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.

Authors:  Guojun Chen; Renata Jaskula-Sztul; Corinne R Esquibel; Irene Lou; Qifeng Zheng; Ajitha Dammalapati; April Harrison; Kevin W Eliceiri; Weiping Tang; Herbert Chen; Shaoqin Gong
Journal:  Adv Funct Mater       Date:  2017-01-17       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.